38429841|t|Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume.
38429841|a|Leber's hereditary optic neuropathy (LHON) is driven by mtDNA mutations affecting Complex I presenting as progressive retinal ganglion cell dysfunction usually in the absence of extra-ophthalmic symptoms. There are no long-term neuroprotective agents for LHON. Oral nicotinamide provides a robust neuroprotective effect against mitochondrial and metabolic dysfunction in other retinal injuries. We explored the potential for nicotinamide to protect mitochondria in LHON by modelling the disease in mice through intravitreal injection of the Complex I inhibitor rotenone. Using MitoV mice expressing a mitochondrial-tagged YFP in retinal ganglion cells we assessed mitochondrial morphology through super-resolution imaging and digital reconstruction. Rotenone induced Complex I inhibition resulted in retinal ganglion cell wide mitochondrial loss and fragmentation. This was prevented by oral nicotinamide treatment. Mitochondrial ultrastructure was quantified by transition electron microscopy, demonstrating a loss of cristae density following rotenone injection, which was also prevented by nicotinamide treatment. These results demonstrate that nicotinamide protects mitochondria during Complex I dysfunction. Nicotinamide has the potential to be a useful treatment strategy for LHON to limit retinal ganglion cell degeneration.
38429841	13	25	nicotinamide	Chemical	MESH:D009536
38429841	50	58	rotenone	Chemical	MESH:D012402
38429841	67	84	neurodegeneration	Disease	MESH:D019636
38429841	133	168	Leber's hereditary optic neuropathy	Disease	MESH:D029242
38429841	170	174	LHON	Disease	MESH:D029242
38429841	251	284	retinal ganglion cell dysfunction	Disease	MESH:D012164
38429841	388	392	LHON	Disease	MESH:D029242
38429841	399	411	nicotinamide	Chemical	MESH:D009536
38429841	461	500	mitochondrial and metabolic dysfunction	Disease	MESH:D028361
38429841	510	526	retinal injuries	Disease	MESH:D012173
38429841	558	570	nicotinamide	Chemical	MESH:D009536
38429841	598	602	LHON	Disease	MESH:D029242
38429841	631	635	mice	Species	10090
38429841	694	702	rotenone	Chemical	MESH:D012402
38429841	716	720	mice	Species	10090
38429841	883	891	Rotenone	Chemical	MESH:D012402
38429841	960	978	mitochondrial loss	Disease	MESH:D028361
38429841	983	996	fragmentation	Disease	MESH:D012892
38429841	1025	1037	nicotinamide	Chemical	MESH:D009536
38429841	1178	1186	rotenone	Chemical	MESH:D012402
38429841	1226	1238	nicotinamide	Chemical	MESH:D009536
38429841	1281	1293	nicotinamide	Chemical	MESH:D009536
38429841	1323	1344	Complex I dysfunction	Disease	MESH:C537475
38429841	1346	1358	Nicotinamide	Chemical	MESH:D009536
38429841	1415	1419	LHON	Disease	MESH:D029242
38429841	1429	1463	retinal ganglion cell degeneration	Disease	MESH:D012162
38429841	Negative_Correlation	MESH:D009536	MESH:D012162
38429841	Positive_Correlation	MESH:D012402	MESH:D019636
38429841	Negative_Correlation	MESH:D009536	MESH:D012173
38429841	Negative_Correlation	MESH:D009536	MESH:D019636
38429841	Positive_Correlation	MESH:D012402	MESH:D012892
38429841	Negative_Correlation	MESH:D009536	MESH:D012892
38429841	Negative_Correlation	MESH:D009536	MESH:D029242
38429841	Positive_Correlation	MESH:D012402	MESH:D028361
38429841	Negative_Correlation	MESH:D009536	MESH:D012402
38429841	Negative_Correlation	MESH:D009536	MESH:D028361
38429841	Negative_Correlation	MESH:D009536	MESH:C537475

